Vytone
- Product NDC
- 44118-704
- 11-digit product format
- 441180704
- Labeler code
- 44118
- Product ID
- 44118-704_261d0f59-4215-9cb4-e063-6294a90ac111
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HYDROCORTISONE ACETATE, IODOQUINOL
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Eckson Labs LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2022-03-30
- Marketing end
- 2027-08-31
- Substance
- HYDROCORTISONE ACETATE; IODOQUINOL
- Active strength
- 19; 10 mg/g; mg/g
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Vytone
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HYDROCORTISONE ACETATE | 19 mg/g |
| IODOQUINOL | 10 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 3X7931PO74, 63W7IE88K8 |
| Rxcui | 1436947, 1436949 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 44118-704-01 | Vytone | 2 g in 1 PACKET | CREAM | 2 | | 2 |
| 44118-704-30 | Vytone | 30 in 1 CARTON | CREAM | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 44118-704 | VYTONE (HYDROCORTISONE ACETATE, IODOQUINOL) CREAM [ECKSON LABS LLC] | 2 | Current NDC, Legacy NDC, 2 package rows | 20241105_db751fea-59d7-314c-e053-2a95a90ae382.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 44118-704-01 | 44118070401 | 2 g in 1 PACKET | 2 g | | | | | Historical |
| 44118-704-30 | 44118070430 | 30 PACKET in 1 CARTON (44118-704-30) / 2 g in 1 PACKET (44118-704-01) | 30 packet | 2022-03-30 | 2027-08-31 | No | No | Current |